InvestWiser

Cell Impact AB

CINasdaq StockholmIndustrialsMarket value 22 m SEK
0.02SEK +14.0%
last day · Price as of 18 November 2026

The answer first

Does Cell Impact beat the market?

No, Cell Impact has not beaten the market over the last year.

Cell Impact−94.6%Stockholm (OMXSGI)+18.7%

Max for seven days

Follow Cell Impact with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Cell Impact

From today, at a price of 0.02 SEK. Write why you follow Cell Impact, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Cell Impact

Your first answer is free, no account needed.

Do you own Cell Impact, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Cell Impact and a few more. Free, no card.

Past year against the exchange and Super Stock
Cell Impact−94.1%Stockholm (OMXSGI)+18.7%Super Stock+45.9%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Cell Impact has fallen 94.6% over the past year, including dividends.
  • The largest fall over the past three years was 99.7%. The price is 100.0% below its peak now.

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

Quality74
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 90 of 328 in industrialsTypical in industrials: 53Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.11
  • Asset turnoverSales divided by everything the company owns0.04
  • Return on equityProfit divided by equity−93.1%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value–
The price · Valuation: the multiples
  • P/BPrice divided by equity0.1
  • P/SPrice divided by sales2.2
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend1
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 332 of 332 in industrialsTypical in industrials: 57Typical in the Nordics: 50

  • 3 months−74.5%
  • 6 months−88.3%
  • 9 months−85.4%
  • 12 months−94.6%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−7.7%
3 years, per year
−76.5%
5 years, per year
−80.2%
10 years, per year
−48.1%
Largest fall, 3 years
−99.7%
From a peak to the bottom
From the peak now
−100.0%
How far the price is from the peak
Volatility, 1 year
121.4%
How much the price swings over a year
Beta, 1 year
−0.11
How much the price moves when the market moves

Return with dividends reinvested.

About Cell Impact

Cell Impact AB is a company in industrials, listed on Nasdaq Stockholm. The share trades in SEK. It has around 26 employees.

Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells and electrolyzers in the United States, Sweden, Other Europe, and Asia. The company provides production series of flow plates; design for manufacturing and other design services; tools and prototypes; local production; and leak testing, cleaning options, and advanced measurement instruments. The company was incorporated in 1999 and is headquartered in Karlskoga, Sweden.

See the full analysis of Cell Impact.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other industrials stocks on Nasdaq Stockholm

Explore the stock market